Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 302

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis

Open access
Kew, Michael C.·2003·Liver International

Abstract

Abstract: Chronic hepatitis B virus (HBV) infection and dietary exposure to aflatoxin B 1 (AFB 1), two of the major risk factors in the multifactorial aetiology of hepatocellular carcinoma (HCC), co‐exist in those countries with the highest incidences of and the youngest patients with this tumour, raising the possibility of a synergistic carcinogenic interaction between the two agents. Experimental studies in HBV‐transgenic mice and woodchucks infected with woodchuck hepatitis virus were the first to show a synergistic hepatocarcinogenic effect between hepadnaviral infection and AFB 1 exposure. With the availability of urinary and serum biomarkers that more accurately reflect dietary exposure to AFB 1 than did the initially used food sampling and dietary questionnaires, cohort studies of patients with HCC in China and Taiwan have provided compelling evidence for a multiplicative or sub‐multiplicative interaction between HBV and AFB 1 in the genesis of human HCC. A number of possible mechanisms for the interaction have been suggested. Chronic HBV infection may induce the cytochrome P450s that metabolise inactive AFB 1 to the mutagenic AFB 1‐8,9‐epoxide. Hepatocyte necrosis and regeneration and the generation of oxygen and nitrogen reactive species resulting from chronic HBV infection increase the likelihood of the AFB 1‐induced p53 249 ser and other mutations and the subsequent clonal expansion of cells containing these mutations. Nuclear excision repair, which is normally responsible for removing AFB 1–DNA adducts, is inhibited by HBV×protein, favouring the persistence of existing mutations. This protein also increases the overall frequency of DNA mutations, including the p53 249 ser mutation, and may contribute to uncontrolled cell cycling when p53 is non‐functional.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1478-3231.2003.00869.x

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 49 references

Cited by

See all 302

Metadata

Authors
Kew, M. C.
Venue
Liver International
Publisher
Wiley
Published
2003-11-27
Volume
23
Issue
6
Pages
405-409
ISSN
  • 0106-9543 (ISSN-L)
  • 1478-3223
  • 1478-3231
OpenAlex
W1969363259
Cited by
302
References
49
FWCI
5.38
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis. https://app.cochat.ai/papers/10.1111/j.1478-3231.2003.00869.x
The paper
Kew, M. C. (2003). Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis. Liver International. https://doi.org/10.1111/j.1478-3231.2003.00869.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.